This is a 12-months' randomized clinical trial that aims at studying the benefit of bilateral hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheimer disease. The benefit of this intervention will be studied in the cognitive, behavioural, quality of life and economic fields. 2groups are involved in this trial: Intervention group: 12 months' treatment with active hearing aids, fitted hearing impairment Control group: 6 months' treatment with placebo hearing aids, followed with 6 months' active hearing aids, fitted hearing impairment
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
51
5 hours per day during the first 6 months (active or inactive upon randomization) 5 hours per day during the last 6 months (active)
Xavier PERROT
Lyon, France
Cognitive benefit evaluated thanks to the ADAS-Cog scale
Time frame: Times of measurements: 0, 6th and 12th month
Cognitive scales: MMSE, Grober and Buschke, Digit symbol test
Time frame: 0, 6th and 12th month
Behavioural scales: IADL, NPI
Time frame: 1st week, 3rd 6th 9th and 12th month
Quality of life scales: Zarit scale and ADRQL
Time frame: Zarit scale(every 2 months during the study time), ADRQL (0, 6th and 12th month)
Consumption questionnaire
Time frame: monthly
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.